Allergan announced in January that the 2019 Wholesale Acquisition Cost (WAC) of the Liletta IUD has increased by 9.5%. However, there will be no price increase for PAA members until April 1, 2019. Members will continue to receive the best price available after the increase. Log...
October 16, 2018 - Allergan and Medicines360 announced that the Food and Drug Administration (FDA) has approved to extend the duration of use of LILETTA (levonorgestrel-releasing intrauterine system) for the prevention of pregnancy for up to 5 years. Did You Know? PAA members receive the lowest available...
PAA's agreement with Allergan not only provides members with a significant discount on the Liletta IUD, but also allows practices to place orders of any size with no minimums. PAA members can receive the lowest available price and have the opportunity to purchase only what is needed. Log in for pricing information and...
Allergan and Medicines360 announced that the Food and Drug Administration (FDA) has approved Liletta (levonorgestrel-releasing intrauterine system) for the prevention of pregnancy for up to 4 years. "The newly approved indication for LILETTA is an important milestone in our work to make this IUD available...